Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin B9  COVID-19 treatment studies for Vitamin B9  C19 studies: Vitamin B9  Vitamin B9   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality, PSM 73% Improvement Relative Risk Mortality, MV, <48hrs 93% Mortality, MV, >48hrs 91% c19early.org/b9 Chen et al. ONS for COVID-19 EARLY TREATMENT Favors ONS Favors control

Early oral nutritional supplement improves COVID-19 outcomes among hospitalized older patients during the omicron wave

Chen et al., Nutrition, doi:10.1016/j.nut.2023.112087
Chen et al., Early oral nutritional supplement improves COVID-19 outcomes among hospitalized older patients during the.., Nutrition, doi:10.1016/j.nut.2023.112087
May 2023   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
PSM retrospective 1,181 COVID-19 patients ≥60 years old in China, showing significantly lower mortality with a nutritional supplement. Hospitalization time and viral clearance time was improved with earlier initiation of treatment. The supplement contained 28 vitamins and minerals including vitamins A, C, D, B9, and zinc. This study is excluded in meta analysis: nutritional supplement containing 28 vitamins and minerals.
This study includes vitamin A, vitamin C, vitamin D, vitamin B9, and zinc.
risk of death, 72.7% lower, RR 0.27, p = 0.03, treatment 3 of 258 (1.2%), control 11 of 258 (4.3%), NNT 32, propensity score matching.
risk of death, 93.0% lower, OR 0.07, p = 0.003, adjusted per study, <48hrs, multivariable, RR approximated with OR.
risk of death, 91.0% lower, OR 0.09, p = 0.005, adjusted per study, >48hrs, multivariable, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Chen et al., 21 May 2023, retrospective, China, peer-reviewed, mean age 78.0, 7 authors, study period April 2022 - June 2022, this trial uses multiple treatments in the treatment arm (combined with 27 vitamins and minerals) - results of individual treatments may vary.
Contact: chenshunjie77csj@163.com, 18916484569@163.com.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin B9All
Abstract: Journal Pre-proof Early oral nutritional supplement improves COVID-19 outcomes among hospitalized older patients during the omicron wave Ying Chen , Yinfan Wu , Wei Ran , Jingjue Yuan , Zhangwei Yang , Shunjie Chen , Ying Wang PII: DOI: Reference: S0899-9007(23)00116-8 https://doi.org/10.1016/j.nut.2023.112087 NUT 112087 To appear in: Nutrition Received date: Revised date: Accepted date: 19 February 2023 16 May 2023 17 May 2023 Please cite this article as: Ying Chen , Yinfan Wu , Wei Ran , Jingjue Yuan , Zhangwei Yang , Shunjie Chen , Ying Wang , Early oral nutritional supplement improves COVID-19 outcomes among hospitalized older patients during the omicron wave, Nutrition (2023), doi: https://doi.org/10.1016/j.nut.2023.112087 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2023 Published by Elsevier Inc. Highlights ONS use among 1181 older patients with COVID-19 was retrospectively studied. ONS use was associated with a lower risk of in-hospital death. Early ONS could also reduce hospital length of stay and days of viral clearance. Timely nutritional support is important for COVID-19 geriatrics. 1 Original Investigation Early oral nutritional supplement improves COVID-19 outcomes among hospitalized older patients during the omicron wave Ying Chen1#, Yinfan Wu1#, Wei Ran1, Jingjue Yuan1, Zhangwei Yang2, Shunjie Chen2*, Ying Wang1* 1 Department of Clinical Nutrition, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, 200434, China 2 Department of Medical Administration, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, 200434, China # These authors contributed equally to this work. * Correspondence author: Shunjie Chen, Ph.D. E-mail: chenshunjie77csj@163.com. Ying Wang, Ph.D. E-mail: 18916484569@163.com; 2 Abstract Background: The effect of and optimal timing for initiating oral nutritional supplement (ONS) on hospitalized older patients with the Omicron variant infection remain unclear. Methods: We collected data from confirmed COVID-19 patients between April 2022 to June 2022 at Shanghai Fourth People’s Hospital, one of the designated medical centers for COVID-19 in Shanghai, China. Patients were identified as ONS users or non-ONS users, and the former was further defined as early ONS (ONS initiated within 48h from hospital admission), and late ONS (ONS initiated after 48 h) users. We conducted a retrospective cohort design as primary analysis and a case-control design as sensitivity analysis to explore the associations between ONS and clinical outcomes. Results: A total of 1181 hospitalized patients ≥60 years old were included in our study. The mean age of the entire cohort was 78.0, and most patients were female (57.7%). The mortalities after PSM were 1.2% and 4.3% in the ONS group and non-ONS groups, respectively (P = 0.032). Subgroup analysis results showed that patients with early-ONS had significantly shorter hospital..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit